Benefits and Features

• Lactobacillus fermentum has been shown to provide a safe and effective approach to preventing, reducing, and resolving lactation discomforts and dysbiosis
• This targeted probiotic supports breast health in nursing mothers. It is designed to extend the benefits of breastfeeding.

Detail Overview

Ther-Biotic® Target b2™ is a targeted probiotic designed to extend the benefits of breastfeeding. Lactobacillus fermentum has been clinically demonstrated to support breast health and resolve discomfort associated with mammary dysbiosis. As many as one-third of lactating women experience significant discomfort resulting in premature cessation of breastfeeding. Studies have shown that certain lactic acid bacteria species, such as L. fermentum, may prevent and resolve lactation-associated mammary dysbiosis. It is recommended to start supplementation with one capsule of Ther-Biotic® Target b2™ in the third trimester of pregnancy and continue while nursing to help prevent mammary dysbiosis.

Caution

Consult your physician If you have any medical condition, or taking prescription drugs, or under the age 18 years. KEEP OUT OF REACH OF CHILDREN.

Made without common allergies: milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat/gluten, soybeans, and sesame. Non-GMO, Vegetarian. No synthetic colors, flavors, or preservatives.

1 capsule, 1 to 3 times daily (3 to 9 billion CFU) or as directed by a healthcare professional.

Recommended serving size: 1 capsule per day in the third trimester of pregnancy and while nursing. Increase to 3 capsules during an active case